Life Sciences
|
DOI: 10.17160/josha.5.4.427
JOSHA’S CRITICAL REVIEW OF “Efficacy of Larotrectinib in TRK Fusion– Positive Cancers in Adults and Children”
R
Roland Mertelsmann, Gerhard G. Steinmann
Albert-Ludwigs Universität
JOSHA´S CONCLUSION. IMPORTANT PROGRESS; ESPECIALLY FOR PATIENTS WITH SARCOMAS FOR WHOM VERY FEW TREATMENT ALTERNATIVES EXIST. TRK-FUSION TESTING SHOULD BECOME ROUTINE IN PATIENTS WITH SARCOMA AND SELECTED PATIENTS WITH OTHER…